Atara Biotherapeutics, Inc. (ATRA)
Nasdaq: ATRA · CIK 0001604464 · United States
Every official Atara Biotherapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ATRA filings
Atara Biotherapeutics, Inc. documents
- Atara Biotherapeutics, Inc. 10-K 2026ATRA 10-K 2026: annual report for fiscal 2026
- Atara Biotherapeutics, Inc. 10-K 2025ATRA 10-K 2025: annual report for fiscal 2025
- Atara Biotherapeutics, Inc. 10-K 2024ATRA 10-K 2024: annual report for fiscal 2024
- Atara Biotherapeutics, Inc. 10-K 2023ATRA 10-K 2023: annual report for fiscal 2023
- Atara Biotherapeutics, Inc. 10-K 2022ATRA 10-K 2022: annual report for fiscal 2022
- Atara Biotherapeutics, Inc. 10-Q 2026ATRA 10-Q 2026: quarterly report for fiscal 2026
- Atara Biotherapeutics, Inc. 10-Q 2025ATRA 10-Q 2025: quarterly report for fiscal 2025
- Atara Biotherapeutics, Inc. 10-Q 2024ATRA 10-Q 2024: quarterly report for fiscal 2024
- Atara Biotherapeutics, Inc. 10-Q 2023ATRA 10-Q 2023: quarterly report for fiscal 2023
- Atara Biotherapeutics, Inc. 10-Q 2022ATRA 10-Q 2022: quarterly report for fiscal 2022
- Atara Biotherapeutics, Inc. 8-K 2026ATRA 8-K 2026: current report for fiscal 2026
- Atara Biotherapeutics, Inc. 8-K 2025ATRA 8-K 2025: current report for fiscal 2025
- Atara Biotherapeutics, Inc. 8-K 2024ATRA 8-K 2024: current report for fiscal 2024
- Atara Biotherapeutics, Inc. 8-K 2023ATRA 8-K 2023: current report for fiscal 2023
- Atara Biotherapeutics, Inc. 8-K 2022ATRA 8-K 2022: current report for fiscal 2022
- Atara Biotherapeutics, Inc. DEF 14A 2026ATRA DEF 14A 2026: proxy statement for fiscal 2026
- Atara Biotherapeutics, Inc. DEF 14A 2025ATRA DEF 14A 2025: proxy statement for fiscal 2025
- Atara Biotherapeutics, Inc. DEF 14A 2024ATRA DEF 14A 2024: proxy statement for fiscal 2024
- Atara Biotherapeutics, Inc. DEF 14A 2023ATRA DEF 14A 2023: proxy statement for fiscal 2023
- Atara Biotherapeutics, Inc. DEF 14A 2022ATRA DEF 14A 2022: proxy statement for fiscal 2022
- Atara Biotherapeutics, Inc. Form 4 2026ATRA Form 4 2026: insider trading filing for fiscal 2026
- Atara Biotherapeutics, Inc. Form 4 2025ATRA Form 4 2025: insider trading filing for fiscal 2025
- Atara Biotherapeutics, Inc. Form 4 2024ATRA Form 4 2024: insider trading filing for fiscal 2024
- Atara Biotherapeutics, Inc. Form 4 2023ATRA Form 4 2023: insider trading filing for fiscal 2023
- Atara Biotherapeutics, Inc. Form 4 2022ATRA Form 4 2022: insider trading filing for fiscal 2022
- Atara Biotherapeutics, Inc. S-1 2026ATRA S-1 2026: registration statement for fiscal 2026
- Atara Biotherapeutics, Inc. S-1 2025ATRA S-1 2025: registration statement for fiscal 2025
- Atara Biotherapeutics, Inc. S-1 2024ATRA S-1 2024: registration statement for fiscal 2024
- Atara Biotherapeutics, Inc. S-1 2023ATRA S-1 2023: registration statement for fiscal 2023
- Atara Biotherapeutics, Inc. S-1 2022ATRA S-1 2022: registration statement for fiscal 2022
- Atara Biotherapeutics, Inc. 13F 2026ATRA 13F 2026: institutional holdings for fiscal 2026
- Atara Biotherapeutics, Inc. 13F 2025ATRA 13F 2025: institutional holdings for fiscal 2025
- Atara Biotherapeutics, Inc. 13F 2024ATRA 13F 2024: institutional holdings for fiscal 2024
- Atara Biotherapeutics, Inc. 13F 2023ATRA 13F 2023: institutional holdings for fiscal 2023
- Atara Biotherapeutics, Inc. 13F 2022ATRA 13F 2022: institutional holdings for fiscal 2022
More companies